Vanderbilt Heart and Vascular Institute (VHVI)

The diversity represented at Vanderbilt Heart Murfreesboro includes, from left, Ahmad Abu-Halimah, MD, Murali Kolli, MD, Ravinder Manda, MD, and David Dantzler, MD.
March 10, 2021

Murfreesboro heart clinic reveals power of diversity

In suburban Murfreesboro, just a short drive off Interstate 24, is one of the most diverse practices and clinics in Vanderbilt Health.

By Matt Batcheldor
February 25, 2021

Driven by passion and persistence, Kim Arnold goes above and beyond to help patients

“Her service and love for our patients translates directly with her quality of work.”

By Matt Batcheldor
January 21, 2021

Congenital Heart Program gains accreditation from ACHA

The Adult Congenital Heart Association (ACHA) has awarded the Vanderbilt Adult Congenital Heart Program status as an Adult Congenital Heart Disease (ACHD) Accredited Comprehensive Care Center — the first in Tennessee.

By Matt Batcheldor
January 7, 2021

Freedman named director of the Division of Cardiovascular Medicine

Jane Freedman, MD, will join Vanderbilt University Medical Center as director of the Division of Cardiovascular Medicine and the physician-in-chief of the Vanderbilt Heart and Vascular Institute, effective Aug. 1.

By Matt Batcheldor
December 17, 2020

Muñoz named to key VHVI leadership role

Daniel Muñoz, MD, MPA, associate professor of Medicine, has been named the new executive medical director of the Patient Care Center (PCC) at Vanderbilt Heart and Vascular Institute (VHVI), effective Jan. 1, 2021.

By Matt Batcheldor
December 10, 2020

VHVI’s Brown, Agrawal receive American Heart Association awards

Two Vanderbilt Heart and Vascular Institute researchers are receiving awards from the American Heart Association.

By Matt Batcheldor
October 22, 2020

Minimally invasive treatment option for AFib studied

A minimally invasive procedure that combines ligation of the left atrial appendage (LAA) with hybrid epicardial-endocardial ablation is a feasible, safe and effective method of treating patients with longstanding atrial fibrillation (AF or AFib), according to a new Vanderbilt-led study.
By Matt Batcheldor
September 17, 2020

New device may aid advanced heart failure patients

Vanderbilt Heart and Vascular Institute (VHVI) has implanted its first V-Wave, an interatrial shunt device, as a part of a multi-center clinical trial.
By Matt Batcheldor
August 4, 2020

Keith Churchwell, MD, appointed president of Yale New Haven Hospital

Former Vanderbilt cardiology leader Keith Churchwell, MD, has been appointed president of Yale New Haven Hospital (YNHH) in Connecticut.
By Doug Campbell
July 30, 2020

Device allows VHVI doctors to monitor heart patients remotely

In 2018, Ronnie Kreis began to develop severe heart failure. After being hospitalized multiple times that year near his home in Oliver Springs in East Tennessee, he was told that nothing else could be done.
By Matt Batcheldor
May 6, 2020

Ventricular assist device program hits major milestone

VHVI’s cardiac surgery and heart failure teams recently celebrated a milestone — implanting the 500th adult patient with a ventricular assist device.
By Matt Batcheldor
March 12, 2020

Tiny pacemaker helps keep patient’s heart in rhythm

In February, Martha Hawks became the Southeast’s first recipient of the Medtronic Micra AV, the latest version of the tiny pacemaker that Vanderbilt Heart and Vascular Institute began testing in a clinical trial in 2014. The FDA approved the latest device in January.
By Matt Batcheldor
February 7, 2020

Hall of Fame company

Hall of Fame wide receiver Raymond Berry wore a tie honoring VUMC when he was named to the NFL’s 100th Anniversary All-Time Team and was recognized at the Super Bowl in Miami on Feb. 2.
By VUMC News and Communications
1 2 3 4 5 … 10